ASML's Rally Encounters a Washington Smog and a CEO's Capacity Caveat
21.06.2026 - 00:20:54 | boerse-global.de
The Dutch lithography giant’s stock touched a fresh 52-week high of €1,691.00 on Thursday, only to recoil the next day to €1,661.20 — a 1.47% drop. The reversal was triggered not by any earnings miss or order delay, but by a suspicion emanating from Washington: US authorities believe China may have acquired an EUV machine from ASML. The company immediately pushed back, telling Reuters that it “never delivered an EUV machine to China — nor any component or assembly specifically designed for an EUV machine.” Public evidence of a transfer remains absent, and the sheer logistics — each unit weighs about 180 tonnes, contains over 100,000 parts, and requires ongoing on-site servicing by ASML — make a clandestine shipment all but implausible.
But the allegation, however thin, underscores a deeper regulatory risk that exists independently of the EUV claim. Since 2019, the Netherlands has banned EUV exports to China under US pressure, and ASML insists it has complied fully. US Commerce Secretary Howard Lutnick has raised the matter directly with ASML executives. More concretely, a bipartisan bill that cleared a US committee in April would extend the ban to include older DUV machines — the very equipment that accounts for roughly 20% of ASML’s projected 2026 revenue from already-approved Chinese orders. That is a tangible threat to the company’s top line, one that would persist even if the EUV smuggling suspicion proves baseless.
Meanwhile, a different kind of pressure is building on the supply side. CEO Christophe Fouquet used a Bloomberg Television interview on Wednesday to warn explicitly about capacity constraints, saying the Terafab mega-project championed by Elon Musk is “a chance, as long as you are not limited by capacity.” The Terafab plan envisions a Texas chip factory costing at least $55 billion and possibly as much as $119 billion, built around ASML’s EUV machines — each priced at roughly $400 million, and ASML is the world’s only supplier. Fouquet’s comment was a pointed reminder that even the most dazzling customer can overwhelm the order book.
Should investors sell immediately? Or is it worth buying Asml?
ASML is already ramping hard. This year the company expects to ship more than 60 EUV systems, up from 48 in 2025, and aims for about 80 units in 2027. JPMorgan analysts have noted that the previously stated capacity ceiling of 90 EUV machines per year is not absolute; production can be expanded without constructing new cleanrooms. But Fouquet’s public caution suggests the management sees the upcoming bottleneck as a real strategic constraint, especially as demand simultaneously surges from South Korean memory makers and the global AI-infrastructure build-out.
Analysts, nonetheless, remain overwhelmingly bullish. In the past month, all nine published ratings have been buys — not a single hold or sell. The average price target over the last three months stands at €1,915, with JPMorgan raising its target to €2,200 from €1,813 earlier in June, citing “significantly more positive” communication from ASML. Bernstein has an “Outperform” with a €1,700 target, Morgan Stanley an “Overweight” at €1,660, and BofA Securities a buy recommendation that projects revenue of €73 billion by 2030 with a gross margin above 60%. The company itself lifted its full-year revenue guidance to a range of €36 billion to €40 billion, up from the previous €34 billion to €39 billion.
None of that optimism has been derailed by Friday’s dip. On a 30-day view, ASML stock has gained nearly 25%, and year-to-date it has advanced more than 68%. From its 52-week low of €593.60 in August 2025, the shares have almost tripled. The decisive questions for the coming weeks and months are whether Washington turns the EUV suspicion into a formal finding — and whether Fouquet can expand production fast enough to keep the Terafab dream, and the broader AI boom, from colliding with hard engineering limits.
Ad
Asml Stock: New Analysis - 21 June
Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
